N. sativa oil | 0.25, 0.5, and 1 μg/mL | 95 h | Gingival fibroblasts | No cytotoxicity | [67] |
N. sativa EE | 0–2 mg/mL | 24 h | Rat L6 muscle cell lineHepG2 cell line | EC50 >2,000 μg/mL against L6myc cell linesEC50 >1,470 μg/mL against HepG2 cell lines | [68] |
N. sativa EE | 100, 500, and 1,000 μg/mL | 48 h | Isolated rat splenocytes | Cytotoxic effects at 500 and 1,000 μg/mL | [57] |
N. sativa EO and ME, PE, CE, AE, and ether extract | 10, 100, and 1,000 μg/mL | 24 h | BSL | Higher toxicity by chloroform and petroleum ether extracts.LC50 petroleum ether: 7 μg/mLLC50 chloroform: 21 μg/mL | [69] |
N. sativa seed VO | 500, 250, 125, and 62.5 μg/mL | Not specified | SCL, SCL-6, SCL-37′6, NUGC-4, Kato-3, 3T6 | LC50 SCL 155.02 μg/mLLC50 SCL-6 185.77 μg/mLLC50 SCL-37′6 120.40 μg/mLLC50 NUGC-4 384.53 μg/mLLC50 3T6 286.83 μg/mL | [70] |
N. sativa PE and AE | 670 μg/mL | 24 h | HL60 | IC50 PE 654 μg/mLIC50 AE >1,000 μg/ml | [71] |
N. sativa EO | 100 mg/mL | 24 h | Huh7 human cells | No cytotoxicity | [72] |
N. sativa seed oil | 50–500 μg/mL | | U-1242, U251, U-87, U-373, A172 and SNB19 | IC50 260 μg/mL | [58] |
AE of N. sativa | 0.5, 1, 4, 8, 9, and 18 mg/mL | | Human C3A cells | Positive micronucleus test extract from Setta | [73] |
N. sativa seed ME, NE, and CE | 2, 2.25, 2.5, 2.75, and 3 μg/mL of methanolic, n-hexane.0.25, 0.5, 0.75, and 1 ng/mL of chloroform | 24 h | HeLa cells | IC50 methanolic: 2.28 μg/mLIC50 n-hexane 2.20 μg/mLIC50 chloroform 0.41 ng/mL | [74] |
N. sativa AE | 79.5 μg/mL | 48 h | F 344 hepatocytes treated with MNNG | ↑ Chromosomal aberrations | [59] |